Abstract
This fifteenth biannual report of the Cochrane Haematological Malignancies Group (CHMG) highlights recently published randomized controlled trials (RCTs) in the field of hemato-oncology, covering the publication period from October 2011 to May 2012. Implications for clinical practice and methodological aspects are the main principles for selecting trials for this report. Studies were identified by electronic search of MEDLINE using a broad search filter that covers all topics in hemato-oncology combined with a highly sensitive search filter for randomized trials (Cochrane Handbook for Systematic Reviews of Interventions).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Benzamides / administration & dosage
-
Bleomycin / administration & dosage
-
Bleomycin / adverse effects
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Dasatinib
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Etoposide / administration & dosage
-
Hodgkin Disease / pathology
-
Hodgkin Disease / radiotherapy
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Lymphoma, Non-Hodgkin / drug therapy*
-
Lymphoma, Non-Hodgkin / mortality
-
Lymphoma, Non-Hodgkin / radiotherapy*
-
Middle Aged
-
Multicenter Studies as Topic
-
Multiple Myeloma / drug therapy*
-
Neoplasm Staging
-
Piperazines / administration & dosage
-
Platelet Transfusion*
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
Primary Prevention
-
Procarbazine / administration & dosage
-
Pyrimidines / administration & dosage
-
Randomized Controlled Trials as Topic
-
Rituximab
-
Stem Cell Transplantation
-
Survival Analysis
-
Thiazoles / administration & dosage
-
Thrombocytopenia / chemically induced
-
Thrombocytopenia / prevention & control
-
Transplantation, Autologous
-
Treatment Outcome
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
-
Vindesine / administration & dosage
-
Vindesine / adverse effects
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Thiazoles
-
Bleomycin
-
Procarbazine
-
Rituximab
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Imatinib Mesylate
-
Cyclophosphamide
-
Dasatinib
-
Vindesine
-
Prednisone
Supplementary concepts
-
BEACOPP protocol
-
CHOP protocol
-
LNH 87 protocol